We're on a mission to create a paradigm shift in the practice of respiratory medicine, starting with earlier, accurate diagnosis.
TidalSense, formerly Cambridge Respiratory Innovations, is a venture-backed respiratory technology company founded in 2013 and headquartered in Cambridge UK.
Our technologies are built on the foundation of our novel patented sensor technology, embedded within N-Tidal, which provides unprecedented insight into lung physiology through high accuracy, rapid sampled CO2, unlike anything seen before in clinical medicine.
Our platform converts N-Tidal CO2 data into over 80 sensitive respiratory biomarkers, in real-time, through analysis of waveform geometry, which fuel our AI diagnostic and monitoring technologies.